Because FTLD-MND has more severe nigrostriatal neuronal loss than ALS (Nishihira et al., 2008; Zhang et al., 2008), FTLD-MND might be more likely to have abnormal findings on DAT-SPECT than ALS. This evidence concerns the gene SLC6A3 and amyotrophic lateral sclerosis.